About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 490301, 14 pages
http://dx.doi.org/10.1155/2012/490301
Research Article

Ginseng Berry Extract Prevents Atherogenesis via Anti-Inflammatory Action by Upregulating Phase II Gene Expression

1Vascular Homeostasis Laboratory and Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Gangwon-do, Chuncheon 200-701, Republic of Korea
2Department of Surgery, Seoul Medical Center, Seoul 131-130, Republic of Korea
3Amorepacific Corporation R&D Center, Gyeonggi-do, Yongin 446-729, Republic of Korea
4Division of Molecular Life Sciences, Ewha Womans University, Seoul 120-750, Republic of Korea
5Department of Biochemistry, College of Sciences, Yonsei University, Seoul 120-749, Republic of Korea

Received 16 August 2012; Accepted 18 October 2012

Academic Editor: Alvin J. Beitz

Copyright © 2012 Chun-Ki Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. P. G. Tipping and W. W. Hancock, “Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques,” American Journal of Pathology, vol. 142, no. 6, pp. 1721–1728, 1993. View at Scopus
  3. B. R. Kwak and F. Mach, “Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties,” Arteriosclerosis, vol. 21, no. 8, pp. 1256–1258, 2001. View at Scopus
  4. K. W. Nam, J. Kim, J. J. Hong et al., “Inhibition of cytokine-induced IκB kinase activation as a mechanism contributing to the anti-atherogenic activity of tilianin in hyperlipidemic mice,” Atherosclerosis, vol. 180, no. 1, pp. 27–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Brand, S. Page, G. Rogler et al., “Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1715–1722, 1996. View at Scopus
  6. L. D. K. Buttery, D. R. Springall, A. H. Chester et al., “Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite,” Laboratory Investigation, vol. 75, no. 1, pp. 77–85, 1996. View at Scopus
  7. E. Galkina and K. Ley, “Vascular adhesion molecules in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2292–2301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Vallabhapurapu and M. Karin, “Regulation and function of NF-κB transcription factors in the immune system,” Annual Review of Immunology, vol. 27, pp. 693–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. J. Surh, J. K. Kundu, and H. K. Na, “Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals,” Planta Medica, vol. 74, no. 13, pp. 1526–1539, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. Park, J. H. Jang, C. Y. Chen, H. K. Na, and Y. J. Surh, “A formulated red ginseng extract rescues PC12 cells from PCB-induced oxidative cell death through Nrf2-mediated upregulation of heme oxygenase-1 and glutamate cysteine ligase,” Toxicology, vol. 278, no. 1, pp. 131–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Chen, P. H. Huang, C. H. Wang et al., “Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract,” Atherosclerosis, vol. 214, no. 2, pp. 301–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Lü, Q. Yao, and C. Chen, “Ginseng compounds: an update on their molecular mechanisms and medical applications,” Current Vascular Pharmacology, vol. 7, no. 3, pp. 293–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Attele, J. A. Wu, and C. S. Yuan, “Ginseng pharmacology: multiple constituents and multiple actions,” Biochemical Pharmacology, vol. 58, no. 11, pp. 1685–1693, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Dey, J. T. Xie, A. Wang, J. Wu, S. A. Maleckar, and C. S. Yuan, “Anti-hyperglycemic effects of ginseng: comparison between root and berry,” Phytomedicine, vol. 10, no. 6-7, pp. 600–605, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Attele, Y. P. Zhou, J. T. Xie et al., “Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component,” Diabetes, vol. 51, no. 6, pp. 1851–1858, 2002. View at Scopus
  16. Y. K. Kim, D. S. Yoo, H. Xu et al., “Ginsenoside content of berries and roots of three typical Korean ginseng (Panax ginseng) cultivars,” Natural Product Communications, vol. 4, no. 7, pp. 903–906, 2009. View at Scopus
  17. J. H. Kim, H. J. Na, C. K. Kim et al., “The non-provitamin A carotenoid, lutein, inhibits NF-κB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-κB-inducing kinase pathways: role of H2O2 in NF-κB activation,” Free Radical Biology and Medicine, vol. 45, no. 6, pp. 885–896, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Lee, H. J. Na, S. Namkoong et al., “4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-κB-DNA-binding activity,” European Journal of Pharmacology, vol. 551, no. 1-3, pp. 143–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. H. J. Jeon, J. H. Choi, I. H. Jung et al., “CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice,” Circulation, vol. 121, no. 9, pp. 1124–1133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Kuhn, N. Tzieply, M. V. Schmidt et al., “Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages,” Free Radical Biology and Medicine, vol. 50, no. 10, pp. 1382–1391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. S. Bae, H. Oh, S. G. Rhee, and Y. D. Yoo, “Regulation of reactive oxygen species generation in cell signaling,” Molecules and Cells, vol. 32, no. 6, pp. 491–509, 2011.
  22. J. H. C. Lin, Y. Zhu, H. L. Liao, Y. Kobari, L. Groszek, and M. B. Stemerman, “Induction of vascular cell adhesion molecule-1 by low-density lipoprotein,” Atherosclerosis, vol. 127, no. 2, pp. 185–194, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Y. Hwang, D. J. Son, I. W. Kim et al., “Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits,” Phytotherapy Research, vol. 22, no. 6, pp. 778–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. K. Siegel, “Ginseng and high blood pressure,” Journal of the American Medical Association, vol. 243, no. 1, p. 32, 1980. View at Scopus
  25. I. W. Joo, J. H. Ryu, and H. J. Oh, “The influence of Sam-Chil-Geun (panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer-407,” Yonsei Medical Journal, vol. 51, no. 4, pp. 504–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ishibashi and Y. Takeishi, “Ezetimibe and vascular inflammation,” Current Vascular Pharmacology, vol. 9, no. 1, pp. 99–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. H. Gutiérrez, M. R. Kuri, and E. R. del Castillo, “Cardiac role of the transcription factor NF-κB,” Cardiovascular and Hematological Disorders, vol. 8, no. 2, pp. 153–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. O. Leung, S. H. Wang, S. H. Lu, W. H. Chou, C. Y. Shiau, and T. C. Chou, “Simvastatin inhibits pro-inflammatory mediators through induction of heme oxygenase-1 expression in lipopolysaccharide-stimulated RAW264. 7 macrophages,” Toxicology Letters, vol. 207, no. 2, pp. 159–166, 2011.
  29. A. Mantovani, F. Bussolino, and E. Dejana, “Cytokine regulation of endothelial cell function,” FASEB Journal, vol. 6, no. 8, pp. 2591–2599, 1992. View at Scopus
  30. P. Libby, P. M. Ridker, and G. K. Hansson, “Inflammation in Atherosclerosis. From Pathophysiology to Practice,” Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2129–2138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Mazière and J. C. Mazière, “Activation of transcription factors and gene expression by oxidized low-density lipoprotein,” Free Radical Biology and Medicine, vol. 46, no. 2, pp. 127–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. J. Lee, S. K. Bai, K. S. Lee et al., “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation,” Molecules and Cells, vol. 16, no. 1, pp. 97–105, 2003. View at Scopus
  33. M. L. Wu, Y. C. Ho, C. Y. Lin, and S. F. Yet, “Heme oxygenase-1 in inflammation and cardiovascular disease,” American Journal of Cardiovascular Disease, vol. 1, no. 2, pp. 150–158, 2011.
  34. J. D. Hayes, J. U. Flanagan, and I. R. Jowsey, “Glutathione transferases,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 51–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Hadad and R. Levy, “The synergistic anti-inflammatory effects of lycopene, lutein, β-carotene, and carnosic acid combinations via redox-based inhibition of NF-κB signaling,” Free Radical Biology and Medicine, vol. 53, no. 7, pp. 1381–1391, 2012.
  36. J. H. Chen, H. P. Ou, C. Y. Lin et al., “Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis,” Chemical Research in Toxicology, vol. 25, no. 9, pp. 1893–1901, 2012.
  37. Q. Sun, Q. T. Meng, Y. Jiang, and Z. Y. Xia, “Ginsenoside Rb1 attenuates intestinal ischemia reperfusion induced renal injury by activating Nrf2/ARE pathway,” Molecules, vol. 17, no. 6, pp. 7195–7205, 2012.
  38. L. Wang, Y. Zhang, Z. Wang et al., “Inhibitory effect of ginsenoside-Rd on carrageenan-induced inflammation in rats,” Canadian Journal of Physiology and Pharmacology, vol. 90, no. 2, pp. 229–236, 2012.
  39. J. Wang, L. Qiao, Y. Li, and G. Yang, “Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion- induced liver injury by inhibiting NF-kappaB activation,” Experimental & molecular medicine, vol. 40, no. 6, pp. 686–698, 2008. View at Scopus
  40. Z. Zhang, X. Li, W. Lv et al., “Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-κB,” Molecular Endocrinology, vol. 22, no. 1, pp. 186–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. B. H. Juulink, “Dietary Nrf2 activators inhibit atherogenic processes,” Atherosclerosis, vol. 225, no. 1, pp. 29–33, 2012. View at Publisher · View at Google Scholar
  42. W. Li, T. O. Khor, C. Xu et al., “Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1485–1489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. S. J. Chapple, R. C. Siow, and G. E. Mann, “Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging,” International Journal of Biochemistry and Cell Biology, vol. 44, no. 8, pp. 1315–1320, 2012.
  44. J. H. Kim, Y. K. Choi, K. S. Lee et al., “Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA,” Free Radical Biology and Medicine, vol. 53, no. 3, pp. 629–640, 2012.
  45. K. Ishikawa, D. Sugawara, X. P. Wang et al., “Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice,” Circulation Research, vol. 88, no. 5, pp. 506–512, 2001. View at Scopus
  46. C. Cheng, A. M. Noordeloos, V. Jeney et al., “Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque,” Circulation, vol. 119, no. 23, pp. 3017–3027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Li, H. Tian, Y. Zhao et al., “Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis,” European Journal of Pharmacology, vol. 672, no. 1–3, pp. 143–152, 2011.